Akari Therapeutics Plc ADR (AKTX)
Market Open
11 Aug, 15:59
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
7. 56
+0.03
+0.3838%
$
8.01M Market Cap
- P/E Ratio
- Div Yield
7,573 Volume
0 Eps
$ 7.53
Previous Close 
Want to track AKTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 0.54 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 56.89 |
AKTX Earnings Reports FAQ
What is the earnings per share (EPS) for AKTX?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately -90.24%, reflecting the AKTX's performance and NASDAQ (CM) market conditions.
When is the next earnings release date?
Akari Therapeutics Plc ADR has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Akari Therapeutics Plc ADR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for AKTX at this time, as Akari Therapeutics Plc ADR has no recent EPS data to calculate it.
